Dental365 Albertson | |
1009 Willis Ave Albertson NY 11507-1333 | |
(516) 747-2215 | |
(516) 344-5748 |
Full Name | Dental365 Albertson |
---|---|
Speciality | Dentist |
Location | 1009 Willis Ave, Albertson, New York |
Authorized Official Name and Position | Hiro Soriano (CHIEF INSURANCE OFFICER) |
Authorized Official Contact | 5163445746 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Dental365 Albertson 3333 New Hyde Park Rd Ste 414 New Hyde Park NY 11042-1224 Ph: (516) 344-5746 | Dental365 Albertson 1009 Willis Ave Albertson NY 11507-1333 Ph: (516) 747-2215 |
NPI Number | 1205316320 |
---|---|
Provider Enumeration Date | 08/17/2018 |
Last Update Date | 08/17/2018 |
Identifier | Type | State | Issuer |
---|---|---|---|
1205316320 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
122300000X | Dentist | (* (Not Available)) | Primary |
News Archive
For a while now, some plastic surgeons have been using stem cells to treat aging, sun-damaged skin. But while they've been getting good results, it's been unclear exactly how these treatments - using adult stem cells harvested from the patient's own body - work to rejuvenate "photoaged" facial skin.
The Robert Wood Johnson Foundation and Bill Thomas, a former nursing home physician, have been working to overhaul the nation's nursing home system by promoting "smaller, home-like facilities," the Wall Street Journal reports.
Levels of non-high-density lipoprotein cholesterol (non-HDL-C) among statin-treated patients appears to be associated with the risk of developing a major cardiovascular event, such as a heart attack or stroke, as are levels of low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B, according to a meta-analysis of data from previously published studies appearing in the March 28 issue of JAMA.
Cerenis Therapeutics SA, a privately held biopharmaceutical company developing HDL-related compounds for the treatment of cardiovascular and metabolic diseases, today announced it will present the results of two clinical proof-of-concept studies for its CER-627 program (niacin/aspirin combinations) at the 78th European Atherosclerosis Society Congress on June 20-23 in Hamburg, Germany.
› Verified 3 days ago
Gmg Dental Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1009 Willis Ave, Albertson, NY 11507 Phone: 516-579-8950 |